Načítá se...
Sporadic adenomatous polyp regression with exisulind is effective but toxic: a randomised, double blind, placebo controlled, dose‐response study
BACKGROUND AND AIM: A 12 month, multicentre, randomised, double blind, placebo controlled, phase 3, dose‐response study was carried out. Exisulind inhibits tumour growth by induction of apoptosis. The aim of our study was to investigate if exisulind induces regression of sporadic colonic adenomas. P...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Group
2006
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1856089/ https://ncbi.nlm.nih.gov/pubmed/16150858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2004.061432 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|